相关实验视频
Updated: May 22, 2025

10:00
Measurement of Lifespan in Drosophila melanogaster
Published on: January 7, 2013
34.1K
美国和欧洲的财富与死亡率之间的关联
Sara Machado1,2, Ilias Kyriopoulos2,3, E John Orav4,5
1Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI.
The New England journal of medicine
|April 2, 2025
概括
富裕的老年人死亡率较低. 与欧洲相比,这种关联在美国更强烈,最富有的欧洲人活得比他们的美国同行长.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
背景情况:
- 越来越多的财富差距需要了解其对老年人健康的影响.
- 关于老年美国人和欧洲人在财富分布上的健康比较,数据有限.
研究的目的:
- 为了比较美国和欧洲的老年人的健康结果,特别是所有原因的死亡率.
- 调查不同国家和地区财富分布与死亡率之间的关联.
主要方法:
- 长度,回顾性队列研究 (2010-2022年) 使用健康和退休研究和健康,衰老和退休在欧洲的调查数据.
- 包括50-85岁的成年人,财富四分位数按国家和年龄组定义.
- 考克斯的比例危险模型用于分析关联,调整年龄,性别,教育和吸烟状况等共变量.
主要成果:
- 更大的财富与所有参与者的全因死亡率降低有关 (HRs在高四分位数与最低四分位数之间从0.60到0.80不等).
- 在美国,最富有和最贫穷的个人之间的生存差距比欧洲更大.
- 北欧/西欧和南欧顶级财富四分之一的生存率超过了最富有的美国人;最富有的美国人的生存率与北欧/西欧最贫穷的美国人相似.
结论:
- 财富增加与美国和欧洲老年人死亡率的降低有关.
- 财富与死亡的关联在美国比在欧洲更为明显.
- 在财富水平和地理区域之间存在显著的生存差异.
相关概念视频
Applications of Life Tables
41
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
41
Life Tables
64
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
64
Actuarial Approach
50
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
50
Assumptions of Survival Analysis
81
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
81
Comparing the Survival Analysis of Two or More Groups
113
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
113
Kaplan-Meier Approach
74
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
74

